Introducing (1S,2R)-(+)-Trans-2-Phenyl-1-Cyclohexanol: Quality and Consistency from the Manufacturer’s Bench

Delivering Pure Chirality for Sensitive Organic Synthesis

Every batch of (1S,2R)-(+)-Trans-2-Phenyl-1-Cyclohexanol begins as a challenge and an opportunity. As manufacturers, the responsibility runs deeper than just making a compound; it stretches into precise stereochemistry and honest purity. Over years on the floor and in the lab, many colleagues and I have watched our customers rely on the subtle difference between the (1S,2R) and (1R,2S) forms. While both might look similar on paper, the directionality of each molecule twists the outcome of a synthesis. The achiral variants never satisfy the demands for selectivity — enantiopure material sets reaction pathways with dependable control, especially in advanced pharmaceuticals and high-value fragrance intermediates.

Our model for this product focuses on high enantiomeric excess, where we target upwards of 98%. This isn’t just a number for a data sheet. Chemists searching for reliable building blocks need confidence that downstream reactions won’t veer in unexpected directions. A racemic blend, even with minor contamination, often throws entire chiral product runs off track. Years of benchwork taught us that careful control at each synthesis step makes the difference between a reliable partner and just another supplier. We insist on clear optical rotation readings for each batch — the transparency helps both sides avoid headaches in application.

Specifications That Reflect Real-World Use

Technical details drive manufacturing, but customers remind us that ultimate success appears in their flasks. The melting range for our product falls between 68 to 72 degrees Celsius. This physical property gives a quick check for chemists preparing to scale reactions: a distinct, narrow melting point signals minimal impurity drift and proper enantiomeric ratio. Over the years, we’ve had partners request custom packaging for moisture-sensitive stockrooms or special labeling for GMP compliance. On those occasions, adapting comes from listening to scientists, not from templated promises or generic assurances.

Particle size hasn’t raised issues for most users, but we keep an ear to variations in solubility. Typically, our (1S,2R)-(+)-Trans-2-Phenyl-1-Cyclohexanol provides a clean, manageable white solid, easy to weigh and handle without elaborate precautions. Water solubility stays low, while solubility in typical solvents like ether or dichloromethane remains steady, supporting standard work-ups for epoxidations, reductions, and Grignard-type additions. Years of handling this product taught us not to lazily trust old data sheets. Any observed changes prompt a direct reevaluation, guided by fresh analytical results — not just what the literature reported decades ago.

Why Chemists Seek This Chiral Cyclohexanol

Demand for (1S,2R)-(+)-Trans-2-Phenyl-1-Cyclohexanol comes from fine chemical, API, and fragrance markets. Many customers use this molecule for constructing more complex chiral centers. It slots into asymmetric synthesis, attaches as a chiral auxiliary, or provides a platform for further elaboration. On a practical level, we’ve seen it incorporated in the multi-step synthesis of beta-lactams, non-steroidal anti-inflammatory drugs, and active pharmaceutical ingredients that hinge on exact chirality of phenyl and hydroxyl substituents. Some research groups report it as a stepping stone in menthol analog design, while others push the aromatic system further for selective oxidations.

Maintaining real traceability matters here. Having stood through countless customer audits, we know that pharmaceutical and GMP users dig far deeper into batch histories than standard research buyers. Our logs connect every step, from choosing starting cyclohexene derivatives to the eventual enantiomeric analysis. This traceability isn’t window dressing; it saves costly delays and avoids nasty surprises when customers validate materials for regulatory submissions or clinical batches. Vendors without direct manufacturing oversight rarely grasp these nuances — it helps when a chemist can pick up the phone and ask about a real deviation, not just an opaque number on a document.

How Our Process Sets Us Apart

Our team controls the synthesis from initial chiral induction through work-up and purification. Working at the source allows careful selection of amino alcohol catalysts, tuning reduction conditions, and screening for potential by-products that could complicate downstream reactivity. In contrast, resellers and third parties may not pinpoint why a batch shows inconsistent chiral purity or hint at subtle contamination with cis isomers.

During a particularly humid summer one year, we saw an uptick in requests concerning batch consistency. Responding from inside the plant, we ran an additional round of Karl Fischer titration, confirming the solid still held to our moisture threshold. This type of real-time adjustment grew from direct shop-floor experience; it reflects a philosophy of leaning into process variation rather than masking it with disclaimers.

Comparing (1S,2R)-(+)-Trans-2-Phenyl-1-Cyclohexanol to Other Cyclohexanol Isomers

Many first-time buyers expect that cyclohexanol derivatives all behave similarly in synthesis. The experience at scale tells a very different story. Even the cis isomers lead to dramatically altered selectivities, often introducing inconsistent stereochemistry or less predictable outcomes in enantioselective transformations. Of particular note, the (1S,2R) arrangement aligns the hydroxyl and phenyl groups trans to each other, producing more crystalline solids and frequently simplifying recrystallization or chromatographic separation.

Some researchers drawn by lower prices of racemic or alternate diastereomers quickly discover higher downstream costs due to rerunning chiral separations, encountering reduced yields, or managing compounded impurities. For applications like catalyst scaffolds, the precise configuration frequently determines whether a synthesis works or fails altogether.

Having manufactured both the (1S,2R) and its mirror (1R,2S), our bench teams regularly troubleshoot why academic procedures falter when applied at pilot scale. We address these issues head-on, recommending process changes that take advantage of our data — for example, leveraging solvent purification to ensure dissolved racemization doesn’t undo delicate chiral induction established earlier in a route.

Support Through Every Stage: From Sourcing to Scale-up

Lab ordering rarely reflects the realities faced in kilo-scale productions. Ordering a few grams from catalog stock covers research, but hundreds of grams or kilos driven by internal manufacture means we anticipate the added stress of larger reactors, new filtration bottlenecks, or unexpected interaction with plant equipment. Over time, we built in-house guidelines to reduce batch-to-batch drift, planning for precise addition rates, variable cooling profiles, and longer crystallization cycles to guarantee consistent purity, even as requests stretch to multi-kilogram lots.

Having real skin in the game means we don’t send a product off blindly. If a batch doesn’t meet agreed chiral excess, our process pauses for full reanalysis. This mindset emerged from tricky experiences early on, where generous interpretations of tolerance once led to wasted time for customer teams working downstream. One customer, synthesizing a statin intermediate, flagged a minute shift in GC retention times — we remedied the route with a tailored purification method, explained the root cause, and put it into our revised SOP. That collaborative spirit, grounded in direct accountability, doesn’t survive in environments split by too many supply chain intermediaries.

Applications Pushing the Field Forward

Organic chemistry stays fueled by reliable starting points. (1S,2R)-(+)-Trans-2-Phenyl-1-Cyclohexanol keeps showing up in novel projects. Some research chemists utilize its chiral core for asymmetric hydrogenation catalysts, while large pharma draws on its structure to navigate complex natural product syntheses. We’ve seen it underpin new excursion-proof fragrance molecules where sensory characteristics shift with the absolute configuration. These real-world stories steer our R&D. When an innovation appears, we consult our toolkit, trial alternate purification steps, or source greener solvents— not just to tick compliance boxes, but to create practical, scalable production that keeps the lab and plant aligned.

Process development never sleeps. One year, a strategic partner shared a new route involving borylation, requiring a specific impurity profile alongside the desired enantiomeric excess. We partnered directly, adjusting synthesis and purification to give precise specifications. This type of collaboration lifts results out of the theoretical — matching bench chemistry to kilogram-scale realities.

Challenges and the Way Forward

Producing chiral intermediates means accepting that minor process variations ripple into end-use performance. The molecular details require constant vigilance — stirring speed, temperature ramp, and even storage conditions shift outcome more drastically than many expect. As manufacturers, we track the market for new analytical advances. Fresh tools like chiral SFC or sensitive NMR probes strengthen QC and demonstrate progressive tightening of specifications.

Sourcing high-purity starting reagents sometimes creates hiccups. Many specialty chemicals rise and fall in availability with global feedstock swings. We address this with diversified supplier audits, backup stocks, and transparent communication about potential delays. Direct manufacturing means facing these challenges without a buffer. If unexpected impurities present a risk, we communicate options with real timelines and technical backup, grounded in hands-on experience instead of vendor platitudes.

Another challenge comes from regulatory and sustainability demands. As conversations worldwide push for greener chemistry, we’ve explored less solvent-intensive methods, enzyme-based reductions, and waste minimization routes. None of this works at scale without keeping both product consistency and shelf-life requirements front of mind. Our team gets feedback loops from customers who pilot new processes, ensuring that greener routes translate to equal or higher reliability, not just lower environmental burden.

Conclusion: Experience and Accountability in Every Drum

Looking over the history of (1S,2R)-(+)-Trans-2-Phenyl-1-Cyclohexanol production, the lessons keep coming not from slogans, but from direct engagement. Chemists on the ground value open feedback, willingness to troubleshoot, and respect for the tiny molecular differences that impact entire research initiatives or commercial production lines. With each lot, we tie together batch integrity, clear analytical results, and application knowledge built up through years on both sides of the laboratory and manufacturing fence. Customers — small labs and global multinationals alike — have guided our standards. Our product stands as a direct result of this ongoing partnership between practical know-how and industry needs. Every detail, from chiral purity to supplier transparency, reflects our commitment as the manufacturer, ready to deliver a dependable, high-value building block for your synthesis journey.